Article 117 – Medical Alley Association

Article 117

MDR Article 117: Implications for Drug-device Combination Products

Manufacturers of combination products should seek regulatory advice and operational support from the expert Celegence team to ensure that essential documentation and clinical evidence for your product portfolio complies under the new MDR. To discuss how our team can strategically partner with yours, reach out to us at info@celegence.com, contact us online or read more about Celegence’s medical device […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER